- IBDEI0QG ; ; 01-FEB-2022
- ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
- Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
- Q Q
- ;;^UTILITY(U,$J,358.3,11897,1,0)
- ;;=^358.31IA^3^2
- ;;^UTILITY(U,$J,358.3,11897,1,2,0)
- ;;=2^J1575
- ;;^UTILITY(U,$J,358.3,11897,1,3,0)
- ;;=3^IMMUNEGLOBULIN/HYALURONIDASE 100MG
- ;;^UTILITY(U,$J,358.3,11898,0)
- ;;=J1833^^48^580^60^^^^1
- ;;^UTILITY(U,$J,358.3,11898,1,0)
- ;;=^358.31IA^3^2
- ;;^UTILITY(U,$J,358.3,11898,1,2,0)
- ;;=2^J1833
- ;;^UTILITY(U,$J,358.3,11898,1,3,0)
- ;;=3^ISAVUCONAZONIUM 1MG
- ;;^UTILITY(U,$J,358.3,11899,0)
- ;;=J2407^^48^580^83^^^^1
- ;;^UTILITY(U,$J,358.3,11899,1,0)
- ;;=^358.31IA^3^2
- ;;^UTILITY(U,$J,358.3,11899,1,2,0)
- ;;=2^J2407
- ;;^UTILITY(U,$J,358.3,11899,1,3,0)
- ;;=3^ORITAVANCIN 10MG
- ;;^UTILITY(U,$J,358.3,11900,0)
- ;;=J2502^^48^580^86^^^^1
- ;;^UTILITY(U,$J,358.3,11900,1,0)
- ;;=^358.31IA^3^2
- ;;^UTILITY(U,$J,358.3,11900,1,2,0)
- ;;=2^J2502
- ;;^UTILITY(U,$J,358.3,11900,1,3,0)
- ;;=3^PASIREOTIDE LONG ACTING 1MG
- ;;^UTILITY(U,$J,358.3,11901,0)
- ;;=J2547^^48^580^91^^^^1
- ;;^UTILITY(U,$J,358.3,11901,1,0)
- ;;=^358.31IA^3^2
- ;;^UTILITY(U,$J,358.3,11901,1,2,0)
- ;;=2^J2547
- ;;^UTILITY(U,$J,358.3,11901,1,3,0)
- ;;=3^PERAMIVIR 1MG
- ;;^UTILITY(U,$J,358.3,11902,0)
- ;;=J2860^^48^580^100^^^^1
- ;;^UTILITY(U,$J,358.3,11902,1,0)
- ;;=^358.31IA^3^2
- ;;^UTILITY(U,$J,358.3,11902,1,2,0)
- ;;=2^J2860
- ;;^UTILITY(U,$J,358.3,11902,1,3,0)
- ;;=3^SILTUXIMAB 10MG
- ;;^UTILITY(U,$J,358.3,11903,0)
- ;;=J7121^^48^580^1^^^^1
- ;;^UTILITY(U,$J,358.3,11903,1,0)
- ;;=^358.31IA^3^2
- ;;^UTILITY(U,$J,358.3,11903,1,2,0)
- ;;=2^J7121
- ;;^UTILITY(U,$J,358.3,11903,1,3,0)
- ;;=3^5% DEXTROSE IN LAC RINGERS UP TO 1000CC
- ;;^UTILITY(U,$J,358.3,11904,0)
- ;;=J7188^^48^580^37^^^^1
- ;;^UTILITY(U,$J,358.3,11904,1,0)
- ;;=^358.31IA^3^2
- ;;^UTILITY(U,$J,358.3,11904,1,2,0)
- ;;=2^J7188
- ;;^UTILITY(U,$J,358.3,11904,1,3,0)
- ;;=3^FACTOR VIII PER IU
- ;;^UTILITY(U,$J,358.3,11905,0)
- ;;=J7205^^48^580^36^^^^1
- ;;^UTILITY(U,$J,358.3,11905,1,0)
- ;;=^358.31IA^3^2
- ;;^UTILITY(U,$J,358.3,11905,1,2,0)
- ;;=2^J7205
- ;;^UTILITY(U,$J,358.3,11905,1,3,0)
- ;;=3^FACTOR VIII FC FUSION PROTEIN PER IU
- ;;^UTILITY(U,$J,358.3,11906,0)
- ;;=J8655^^48^580^78^^^^1
- ;;^UTILITY(U,$J,358.3,11906,1,0)
- ;;=^358.31IA^3^2
- ;;^UTILITY(U,$J,358.3,11906,1,2,0)
- ;;=2^J8655
- ;;^UTILITY(U,$J,358.3,11906,1,3,0)
- ;;=3^NETUPITANT 300MG AND PALONOSETRON 0.5MG
- ;;^UTILITY(U,$J,358.3,11907,0)
- ;;=J9032^^48^580^19^^^^1
- ;;^UTILITY(U,$J,358.3,11907,1,0)
- ;;=^358.31IA^3^2
- ;;^UTILITY(U,$J,358.3,11907,1,2,0)
- ;;=2^J9032
- ;;^UTILITY(U,$J,358.3,11907,1,3,0)
- ;;=3^BELINOSTAT 10MG
- ;;^UTILITY(U,$J,358.3,11908,0)
- ;;=J9039^^48^580^21^^^^1
- ;;^UTILITY(U,$J,358.3,11908,1,0)
- ;;=^358.31IA^3^2
- ;;^UTILITY(U,$J,358.3,11908,1,2,0)
- ;;=2^J9039
- ;;^UTILITY(U,$J,358.3,11908,1,3,0)
- ;;=3^BLINATUMOMAB 1MCG
- ;;^UTILITY(U,$J,358.3,11909,0)
- ;;=J9299^^48^580^79^^^^1
- ;;^UTILITY(U,$J,358.3,11909,1,0)
- ;;=^358.31IA^3^2
- ;;^UTILITY(U,$J,358.3,11909,1,2,0)
- ;;=2^J9299
- ;;^UTILITY(U,$J,358.3,11909,1,3,0)
- ;;=3^NIVOLUMAB 1MG
- ;;^UTILITY(U,$J,358.3,11910,0)
- ;;=J9308^^48^580^93^^^^1
- ;;^UTILITY(U,$J,358.3,11910,1,0)
- ;;=^358.31IA^3^2
- ;;^UTILITY(U,$J,358.3,11910,1,2,0)
- ;;=2^J9308
- ;;^UTILITY(U,$J,358.3,11910,1,3,0)
- ;;=3^RAMUCIRUMAB 5MG
- ;;^UTILITY(U,$J,358.3,11911,0)
- ;;=J3301^^48^580^61^^^^1
- ;;^UTILITY(U,$J,358.3,11911,1,0)
- ;;=^358.31IA^3^2
- ;;^UTILITY(U,$J,358.3,11911,1,2,0)
- ;;=2^J3301
- ;;^UTILITY(U,$J,358.3,11911,1,3,0)
- ;;=3^KENALOG 10MG
- ;;^UTILITY(U,$J,358.3,11912,0)
- ;;=J3380^^48^580^109^^^^1
- ;;^UTILITY(U,$J,358.3,11912,1,0)
- ;;=^358.31IA^3^2
- --- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI0QG 3774 printed Feb 18, 2025@23:20:08 Page 2
- IBDEI0QG ; ; 01-FEB-2022
- +1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
- +2 if 'DIFQR(358.3)
- QUIT
- FOR I=1:2
- SET X=$TEXT(Q+I)
- if X=""
- QUIT
- SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
- SET X=$EXTRACT(X,4,999)
- if $ASCII(Y)=126
- SET I=I+1
- SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
- if $ASCII(Y)=61
- SET Y=$EXTRACT(Y,2,999)
- XECUTE NO
- IF '$TEST
- SET @X=Y
- Q QUIT
- +1 ;;^UTILITY(U,$J,358.3,11897,1,0)
- +2 ;;=^358.31IA^3^2
- +3 ;;^UTILITY(U,$J,358.3,11897,1,2,0)
- +4 ;;=2^J1575
- +5 ;;^UTILITY(U,$J,358.3,11897,1,3,0)
- +6 ;;=3^IMMUNEGLOBULIN/HYALURONIDASE 100MG
- +7 ;;^UTILITY(U,$J,358.3,11898,0)
- +8 ;;=J1833^^48^580^60^^^^1
- +9 ;;^UTILITY(U,$J,358.3,11898,1,0)
- +10 ;;=^358.31IA^3^2
- +11 ;;^UTILITY(U,$J,358.3,11898,1,2,0)
- +12 ;;=2^J1833
- +13 ;;^UTILITY(U,$J,358.3,11898,1,3,0)
- +14 ;;=3^ISAVUCONAZONIUM 1MG
- +15 ;;^UTILITY(U,$J,358.3,11899,0)
- +16 ;;=J2407^^48^580^83^^^^1
- +17 ;;^UTILITY(U,$J,358.3,11899,1,0)
- +18 ;;=^358.31IA^3^2
- +19 ;;^UTILITY(U,$J,358.3,11899,1,2,0)
- +20 ;;=2^J2407
- +21 ;;^UTILITY(U,$J,358.3,11899,1,3,0)
- +22 ;;=3^ORITAVANCIN 10MG
- +23 ;;^UTILITY(U,$J,358.3,11900,0)
- +24 ;;=J2502^^48^580^86^^^^1
- +25 ;;^UTILITY(U,$J,358.3,11900,1,0)
- +26 ;;=^358.31IA^3^2
- +27 ;;^UTILITY(U,$J,358.3,11900,1,2,0)
- +28 ;;=2^J2502
- +29 ;;^UTILITY(U,$J,358.3,11900,1,3,0)
- +30 ;;=3^PASIREOTIDE LONG ACTING 1MG
- +31 ;;^UTILITY(U,$J,358.3,11901,0)
- +32 ;;=J2547^^48^580^91^^^^1
- +33 ;;^UTILITY(U,$J,358.3,11901,1,0)
- +34 ;;=^358.31IA^3^2
- +35 ;;^UTILITY(U,$J,358.3,11901,1,2,0)
- +36 ;;=2^J2547
- +37 ;;^UTILITY(U,$J,358.3,11901,1,3,0)
- +38 ;;=3^PERAMIVIR 1MG
- +39 ;;^UTILITY(U,$J,358.3,11902,0)
- +40 ;;=J2860^^48^580^100^^^^1
- +41 ;;^UTILITY(U,$J,358.3,11902,1,0)
- +42 ;;=^358.31IA^3^2
- +43 ;;^UTILITY(U,$J,358.3,11902,1,2,0)
- +44 ;;=2^J2860
- +45 ;;^UTILITY(U,$J,358.3,11902,1,3,0)
- +46 ;;=3^SILTUXIMAB 10MG
- +47 ;;^UTILITY(U,$J,358.3,11903,0)
- +48 ;;=J7121^^48^580^1^^^^1
- +49 ;;^UTILITY(U,$J,358.3,11903,1,0)
- +50 ;;=^358.31IA^3^2
- +51 ;;^UTILITY(U,$J,358.3,11903,1,2,0)
- +52 ;;=2^J7121
- +53 ;;^UTILITY(U,$J,358.3,11903,1,3,0)
- +54 ;;=3^5% DEXTROSE IN LAC RINGERS UP TO 1000CC
- +55 ;;^UTILITY(U,$J,358.3,11904,0)
- +56 ;;=J7188^^48^580^37^^^^1
- +57 ;;^UTILITY(U,$J,358.3,11904,1,0)
- +58 ;;=^358.31IA^3^2
- +59 ;;^UTILITY(U,$J,358.3,11904,1,2,0)
- +60 ;;=2^J7188
- +61 ;;^UTILITY(U,$J,358.3,11904,1,3,0)
- +62 ;;=3^FACTOR VIII PER IU
- +63 ;;^UTILITY(U,$J,358.3,11905,0)
- +64 ;;=J7205^^48^580^36^^^^1
- +65 ;;^UTILITY(U,$J,358.3,11905,1,0)
- +66 ;;=^358.31IA^3^2
- +67 ;;^UTILITY(U,$J,358.3,11905,1,2,0)
- +68 ;;=2^J7205
- +69 ;;^UTILITY(U,$J,358.3,11905,1,3,0)
- +70 ;;=3^FACTOR VIII FC FUSION PROTEIN PER IU
- +71 ;;^UTILITY(U,$J,358.3,11906,0)
- +72 ;;=J8655^^48^580^78^^^^1
- +73 ;;^UTILITY(U,$J,358.3,11906,1,0)
- +74 ;;=^358.31IA^3^2
- +75 ;;^UTILITY(U,$J,358.3,11906,1,2,0)
- +76 ;;=2^J8655
- +77 ;;^UTILITY(U,$J,358.3,11906,1,3,0)
- +78 ;;=3^NETUPITANT 300MG AND PALONOSETRON 0.5MG
- +79 ;;^UTILITY(U,$J,358.3,11907,0)
- +80 ;;=J9032^^48^580^19^^^^1
- +81 ;;^UTILITY(U,$J,358.3,11907,1,0)
- +82 ;;=^358.31IA^3^2
- +83 ;;^UTILITY(U,$J,358.3,11907,1,2,0)
- +84 ;;=2^J9032
- +85 ;;^UTILITY(U,$J,358.3,11907,1,3,0)
- +86 ;;=3^BELINOSTAT 10MG
- +87 ;;^UTILITY(U,$J,358.3,11908,0)
- +88 ;;=J9039^^48^580^21^^^^1
- +89 ;;^UTILITY(U,$J,358.3,11908,1,0)
- +90 ;;=^358.31IA^3^2
- +91 ;;^UTILITY(U,$J,358.3,11908,1,2,0)
- +92 ;;=2^J9039
- +93 ;;^UTILITY(U,$J,358.3,11908,1,3,0)
- +94 ;;=3^BLINATUMOMAB 1MCG
- +95 ;;^UTILITY(U,$J,358.3,11909,0)
- +96 ;;=J9299^^48^580^79^^^^1
- +97 ;;^UTILITY(U,$J,358.3,11909,1,0)
- +98 ;;=^358.31IA^3^2
- +99 ;;^UTILITY(U,$J,358.3,11909,1,2,0)
- +100 ;;=2^J9299
- +101 ;;^UTILITY(U,$J,358.3,11909,1,3,0)
- +102 ;;=3^NIVOLUMAB 1MG
- +103 ;;^UTILITY(U,$J,358.3,11910,0)
- +104 ;;=J9308^^48^580^93^^^^1
- +105 ;;^UTILITY(U,$J,358.3,11910,1,0)
- +106 ;;=^358.31IA^3^2
- +107 ;;^UTILITY(U,$J,358.3,11910,1,2,0)
- +108 ;;=2^J9308
- +109 ;;^UTILITY(U,$J,358.3,11910,1,3,0)
- +110 ;;=3^RAMUCIRUMAB 5MG
- +111 ;;^UTILITY(U,$J,358.3,11911,0)
- +112 ;;=J3301^^48^580^61^^^^1
- +113 ;;^UTILITY(U,$J,358.3,11911,1,0)
- +114 ;;=^358.31IA^3^2
- +115 ;;^UTILITY(U,$J,358.3,11911,1,2,0)
- +116 ;;=2^J3301
- +117 ;;^UTILITY(U,$J,358.3,11911,1,3,0)
- +118 ;;=3^KENALOG 10MG
- +119 ;;^UTILITY(U,$J,358.3,11912,0)
- +120 ;;=J3380^^48^580^109^^^^1
- +121 ;;^UTILITY(U,$J,358.3,11912,1,0)
- +122 ;;=^358.31IA^3^2